FS120 for Cancer

MD Anderson Cancer Center, Houston, TX
Cancer+1 More ConditionsFS120 - Drug
All Sexes

Study Summary

This trial is testing a new drug, FS120, to see if it is safe and effective in treating people with advanced cancer.

Eligible Conditions
  • Advanced Cancer
  • Metastatic Cancer

Treatment Effectiveness

Phase-Based Effectiveness

1 of 3
Phase 1

Study Objectives

2 Primary · 0 Secondary · Reporting Duration: 15 months

15 months
Incidence, severity, and duration of adverse events (AEs), serious adverse events (SAEs) and dose limiting toxicities (DLTs)
28 days
Determination of a maximum tolerated dose (MTD) and/or recommended Phase 2 dose (RP2D) by evaluation of DLTs

Trial Safety

Phase-Based Safety

1 of 3

Awards & Highlights

No Placebo Group
All patients enrolled in this trial will receive the new treatment.

Trial Design

2 Treatment Groups

FS120 Q4W
1 of 2
1 of 2

Experimental Treatment

277 Total Participants · 2 Treatment Groups

Primary Treatment: FS120 · No Placebo Group · Phase 1

FS120 Q4W
Experimental Group · 1 Intervention: FS120 · Intervention Types: Drug
Experimental Group · 1 Intervention: FS120 · Intervention Types: Drug

Trial Logistics

Trial Timeline

Screening: ~3 weeks
Treatment: Varies
Reporting: 15 months

Who is running the clinical trial?

Merck Sharp & Dohme LLCIndustry Sponsor
3,737 Previous Clinical Trials
4,973,553 Total Patients Enrolled
F-star Therapeutics LimitedLead Sponsor
2 Previous Clinical Trials
257 Total Patients Enrolled

Eligibility Criteria

Age 18+ · All Participants · 1 Total Inclusion Criteria

Mark “Yes” if the following statements are true for you:
You must use a very reliable form of birth control during the study.

Frequently Asked Questions

What is the maximum number of individuals permitted to join this clinical trial?

"Absolutely, the published information on clinicaltrials.gov attests to this trial's ongoing recruitment process which commenced in November 2020 and was last updated in August of 2022. There is need for 277 volunteers across three locations." - Anonymous Online Contributor

Unverified Answer

Are there currently any vacancies for participants of this clinical trial?

"Indeed, the information posted on clinicaltrials.gov confirms that this study is still open for recruitment. It was initially listed on November 18th 2020 and most recently updated in August 8th 2022. The researchers are aiming to acquire 277 patients from 3 different sites." - Anonymous Online Contributor

Unverified Answer

Has the FS120 medication been given clearance by the FDA?

"FS120 is currently being assessed in a Phase 1 trial, thus the safety rating for this medication was registered as a score of 1 due to scant evidence indicating its efficacy and security." - Anonymous Online Contributor

Unverified Answer
Please Note: These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.